Despite this, Bcl3 loss in two transgenic models of breast cancer resulted in no change to primary tumour growth, but affected progression to metastasis [22,23], suggesting that Bcl3 may be more important in established tumours than tumourigenesis in the p53wt setting. The gene discussed is BCL3; the disease is breast cancer.